Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1α action in mouse mammary tumor cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 71, Issue 1-2, 1999, Pages 71-81

  Hida, Naïma ^a   Poulin, Richard ^a   Veilleux, Raymonde ^a   Labrie, Fernand ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; INTERLEUKIN 1ALPHA; ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ARTICLE; BREAST TUMOR; CELL CLONE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HORMONE BINDING; HORMONE DEPENDENCE; HORMONE SENSITIVITY; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STEROID METABOLISM; TUMOR CELL LINE;

ANDROGENS; ANDROSTENEDIOL; ANDROSTENEDIONE; ANIMALS; BINDING SITES; CELL DIVISION; CLONE CELLS; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; INTERLEUKIN-1; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MITOGENS; NEOPLASMS, HORMONE-DEPENDENT; ORNITHINE DECARBOXYLASE; STEROIDS; TESTOSTERONE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032756541     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00120-X     Document Type: Article

References (47)

1. Labrie F., Veilleux R. A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate. 8:1986;293-300.
2. Nicolson G.L. Tumor cell instability, diversification and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1987;1473-1487.
3. Fujii H., Marsh C., Cairns P., Sidransky D., Gabrielson E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res. 56:1996;1493-1497.
4. Malins D.C., Polissar N.L., Gunselman S.J. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA. 93:1996;2557-2563.
5. Clarke R., Thompson E.W., Leonessa F., Lippman J., McGarvey M., Frandsen T.L., Brünner N. Hormone resistance, invasiveness and metastatic potential in breast cancer. Breast Cancer Res. Treat. 24:1993;227-239.
6. Labrie F., Dupont A., Bélanger A. Complete androgen blockade for the treatment of prostate cancer. De Vita V.T., Hellman S., Rosenberg S.A. Important Advances in Oncology. 1985;193-217 J.B. Lipincott, Philadelphia.
7. Nandi S., Guzman R.C., Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Natl. Acad. Sci. USA. 92:1995;3650-3657.
8. Yamaguchi T., Kawamoto K., Uchida N., Uchida K., Watanabe S. Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115. In Vitro Cell. Dev. Biol. 28A:1992;245-254.
9. Darbre P.D., King R.J.B. Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors. Cell. 51:1987;521-528.
10. Labrie F., Veilleux R., Fournier A. Low androgen levels induce the development of androgen-hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture. J. Natl. Cancer Inst. 80:1988;1138-1147.
11. Lefebvre Y.A., Caskey J.J., Kline L.D. Characterization of androgen uptake by purified nuclei from an androgen-dependent and two androgen-independent cell lines of Shionogi mouse mammary carcinoma. J. Steroid Biochem. 17:1982;609-614.
12. Griffin J.E., Allman D.R., Durrant J.L., Wilson J.D. Variation in steroid 5α-reductase activity in cloned human skin fibroblasts: shift in phenotypic expression from high to low activity upon subcloning. J. Biol. Chem. 256:1981;3662-3666.
13. Daly R.J., Carrick N., Darbre P.D. Progression to steroid autonomy is accompanied by altered sensitivity to growth factors in S115 mouse mammary tumour cells. J. Steroid Biochem. Mol. Biol. 54:1995;21-29.
14. Sato B., Kouhara H., Koga M., Kayasama S., Saito H., Sumitani S., Hashimoto K., Kishimoto T., Tanaka A., Matsumoto K. Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells. J. Steroid Biochem. Mol. Biol. 47:1993;91-98.
15. Tanaka A., Miyamoto K., Minamino N., Takeda M., Sato B., Matsuo H., Matsumoto K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA. 89:1992;8928-8932.
16. Sorger T., Germinario R.J. A direct solubilization procedure for the determination of DNA and protein in cultured fibroblast monolayers. Anal. Biochem. 131:1983;254-256.
17. Luthy I., Labrie F. Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamide. Prostate. 10:1987;89-94.
18. Rodbard D. Apparent positive cooperative effect in cyclic AMP and corticosterone production by isolated cells in response to ACTH analogs. Endocrinology. 94:1974;1427-1437.
19. Poulin R., Baker D., Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat. 12:1988;213-225.
20. Scatchard G. The attraction of protein for small molecules and ions. Ann. NY Acad. Sci. 51:1949;660-672.
21. Bélanger A., Couture J., Caron S., Roy R. Determination of nonconjugated and conjugated steroid levels in plasma and prostate after separation on C18 columns. Ann. NY Acad. Sci. 595:1990;251-259.
22. Brochu M., Bélanger A. Increase in plasma steroid glucuronide levels in men from infancy to adulthood. J. Clin. Endocrinol. Metab. 64:1987;1283-1287.
23. Provencher P., Lorrain A., Bélanger A. Increase in plasma steroid glucuronide levels in men from infancy to adulthood. J. Endocrinol. 30:1987;71-78.
24. Poulin R., Secrist J.A. III, Pegg A.E. Effect of 1-amino-oxy-3-aminopropane on polyamine metabolism and growth of L1210 cells. Biochem. J. 263:1989;215-221.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
26. Kramer C.Y. Extension of multiple-range tests to group means with unequal numbers of replications. Biometrics. 12:1956;307-310.
27. Bégin D., Luthy I.A., Labrie F. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell. Endocrinol. 58:1988;213-219.
28. Neri R., Florance K., P K., Van Cleave S. A biological profile of a non steroidal antiandrogen, SCH13521, (4′-nitro-3′-trifluoromethylisobutyranilide). Endocrinology. 91:1971;427-437.
29. Bardin C.W., Catterall J.F. Testosterone: a major determinant of extragenital sexual dimorphism. Science. 211:1981;1285-1294.
30. Pegg A.E., McCann P.P. Polyamine metabolism and function. Am. J. Physiol. 243:1982;C212-C221.
31. Fredlund J.O., Johansson M.C., Dahlberg E., Oredsson S.M. Ornithine decarboxylase and S-adenosylmethionine decarboxylase expression during the cell cycle of Chinese hamster ovary cells. Exp. Cell Res. 216:1995;86-92.
32. Jänne O.A., Crozat A., Palvimo J., Eisenberg L.M. Androgen-regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase genes. J. Steroid Biochem. Mol. Biol. 40:1991;307-315.
33. Scalabrino G., Lorenzini E.C. Polyamines and mammalian hormones, Part II. Paracrine signals and intracellular regulators. Mol. Cell. Endocrinol. 77:1991;37-56.
34. Danforth D.N. Jr, Sgagias M.K. Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res. 53:1993;1538-1545.
35. Costantino A., Vinci C., Mineo R., Frasca F., Pandini G., Milazzo G., Vigneri R., Belfiore A. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity. Endocrinology. 137:1996;4100-4107.
36. Rochefort H., Garcia M. The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharm. Ther. 23:1984;193-216.
37. Suzuki N., Miyauchi T., Urata M., Yazawa H., Shimazaki J., Hosoya T. Effect of androgen on ornithine decarboxylase activity in androgen-dependent mouse mammary tumor (Shionogi carcinoma 115) and its androgen-independent subline (CS 2). Endocrinol. Jpn. 33:1986;233-238.
38. Watson G., Paigen P. mRNA synthesis rates for androgen-inducible sequences in mouse kidney. Mol. Cell. Biol. 8:1988;2117-2124.
39. Rinehart C.A. Jr, Canellakis E.S. Induction of ornithine decarboxylase by insulin and growth factors is mediated by amino acids. Proc. Natl. Acad. Sci. USA. 82:1985;4365-4368.
40. Chen Z.P., Chen K.Y. Mechanism of regulation of ornithine decarboxylase gene expression by asparagine in a variant mouse neuroblastoma cell line. J. Biol. Chem. 267:1992;6946-6951.
41. Poulin R., Pegg A.E. Regulation of ornithine decarboxylase expression by anisosmotic shock in α-difluoromethylornithine-resistant L1210 cells. J. Biol. Chem. 265:1990;4025-4032.
42. Nonomura N., Nakamura N., Uchida N., Noguchi S., Sato B., Sonoda T., Matsumoto K. Growth stimulatory effect of androgen-induced autocrine growth factor(s) secreted from Shionogi Carcinoma 115 cells on androgen-unresponsive cancer cells in a paracrine mechanism. Cancer Res. 48:1988;4904-4908.
43. Huber M., Poulin R. Post-translational cooperativity of ornithine decarboxylase induction by estrogens and peptide growth factors in human breast cancer cells. Mol. Cell. Endocrinol. 117:1996;211-218.
44. Philips A., Chalbos D., Rochefort H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem. 268:1993;14103-14108.
45. Weiner K.X.B., Dias J.A. Protein synthesis is required for testosterone to decrease ornithine decarboxylase messenger RNA levels in rat Sertoli cells. Mol. Endocrinol. 4:1990;1791-1798.
46. White M.W., Kameji T., Pegg A.E., Morris D.R. Increased efficiency of translation of ornithine decarboxylase mRNA in mitogen-activated lymphocytes. Eur. J. Biochem. 170:1987;87-92.
47. Kren B.T., Steer C.J. Posttranscriptional regulation of gene expression in liver regeneration: role of mRNA stability. FASEB J. 10:1996;559-573.